Literature DB >> 7940927

The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine.

D W Holt1, E A Mueller, J M Kovarik, J B van Bree, K Kutz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7940927

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  11 in total

Review 1.  Therapeutic drug monitoring of immunosuppressant drugs.

Authors:  A Johnston; D W Holt
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

2.  Cyclosporin for refractory ulcerative colitis.

Authors:  C G Loftus; E V Loftus; W J Sandborn
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

3.  Evaluation of pharmacokinetic interaction between cyclosporin A and probucol in rats.

Authors:  Mari Jiko; Ikuko Yano; Hiroko Wakasugi; Hideyuki Saito; Ken-ichi Inui
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

4.  [Cyclosporine monitoring in patients with chronic uveitis].

Authors:  S Schmidt; U Pleyer
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

Review 5.  Prevention of transplant rejection: current treatment guidelines and future developments.

Authors:  N Perico; G Remuzzi
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

6.  Prediction of drug solubility in lipid mixtures from the individual ingredients.

Authors:  Mark Sacchetti; Elham Nejati
Journal:  AAPS PharmSciTech       Date:  2012-08-21       Impact factor: 3.246

7.  Clinical studies with oral lipid based formulations of poorly soluble compounds.

Authors:  Dimitrios G Fatouros; Ditte M Karpf; Flemming S Nielsen; Anette Mullertz
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

Review 8.  Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects.

Authors:  P P Constantinides
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

9.  Improved absorption of cyclosporin A from a new microemulsion formulation: implications for dosage and monitoring.

Authors:  A Bökenkamp; G Offner; P F Hoyer; U Vester; K Wonigeit; J Brodehl
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

10.  A review on therapeutic drug monitoring of immunosuppressant drugs.

Authors:  Niloufar Mohammadpour; Sepideh Elyasi; Naser Vahdati; Amir Hooshang Mohammadpour; Jamal Shamsara
Journal:  Iran J Basic Med Sci       Date:  2011-11       Impact factor: 2.699
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.